78
Views
3
CrossRef citations to date
0
Altmetric
Review

CNS germinomas: what is the best treatment strategy?

, , , , , , , & show all
Pages 1527-1536 | Published online: 09 Jan 2014

References

  • Koide O, Watanabe Y, Sato K. Pathological survey of intracranial germinoma and pinealoma in Japan. Cancer45(8), 2119–2130 (1980).
  • Bjornsson J, Scheithauer BW, Okazaki H, Leech RW. Intracranial germ cell tumors: pathobiological and immunohistochemical aspects of 70 cases. J. Neuropathol. Exp. Neurol.44(1), 32–46 (1985).
  • Rich TA, Cassady JR, Strand RD, Winston KR. Radiation therapy for pineal and suprasellar germ cell tumors. Cancer55(5), 932–940 (1985).
  • Kretschmar CS. Germ cell tumors of the brain in children: a review of current literature and new advances in therapy. Cancer Invest.15(2), 187–198 (1997).
  • Linggood RM, Chapman PH. Pineal tumors. J. Neurooncol.12(1), 85–91 (1992).
  • Paulino AC, Wen BC, Mohideen MN. Controversies in the management of intracranial germinomas. Oncology (Williston Park, NY)13(4), 513–521 (1999).
  • Haddock MG, Schild SE, Scheithauer BW, Schomberg PJ. Radiation therapy for histologically confirmed primary central nervous system germinoma. Int. J. Radiat. Oncol. Biol. Phys.38(5), 915–923 (1997).
  • Amendola BE, McClatchey K, Amendola MA. Pineal region tumors: ana­lysis of treatment results. Int. J. Radiat. Oncol. Biol. Phys.10(7), 991–997 (1984).
  • Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O. Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors. Childs Nerv. Syst.14(1–2), 59–62 (1998).
  • Sawamura Y, Shirato H, Ikeda J et al. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J. Neurosurg.88(1), 66–72 (1998).
  • Legido A, Packer RJ, Sutton LN et al. Suprasellar germinomas in childhood. A reappraisal. Cancer63(2), 340–344 (1989).
  • Regis J, Bouillot P, Rouby-Volot F, Figarella-Branger D, Dufour H, Peragut JC. Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases. Neurosurgery39(5), 907–912 (1996).
  • Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg.63(2), 155–167 (1985).
  • Berger MS, Baumeister B, Geyer JR, Milstein J, Kanev PM, LeRoux PD. The risks of metastases from shunting in children with primary central nervous system tumors. J. Neurosurg.74(6), 872–877 (1991).
  • Fuller BG, Kapp DS, Cox R. Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. Int. J. Radiat. Oncol. Biol. Phys.28(1), 229–245 (1994).
  • Sawamura Y, de Tribolet N, Ishii N, Abe H. Management of primary intracranial germinomas: diagnostic surgery or radical resection? J. Neurosurg.87(2), 262–266 (1997).
  • Aydin F, Ghatak NR, Radie-Keane K, Kinard J, Land SD. The short-term effect of low-dose radiation on intracranial germinoma. A pathologic study. Cancer69(9), 2322–2326 (1992).
  • Hardenbergh PH, Golden J, Billet A et al. Intracranial germinoma: the case for lower dose radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.39(2), 419–426 (1997).
  • Bamberg M, Kortmann RD, Calaminus G et al. Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J. Clin. Oncol.17(8), 2585–2592 (1999).
  • Aoyama H, Shirato H, Kakuto Y et al. Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother. Oncol.47(2), 201–205 (1998).
  • Shibamoto Y, Takahashi M, Abe M. Reduction of the radiation dose for intracranial germinoma: a prospective study. Br. J. Cancer70(5), 984–989 (1994).
  • Shibamoto Y, Abe M, Yamashita J et al. Treatment results of intracranial germinoma as a function of the irradiated volume. Int. J. Radiat. Oncol. Biol. Phys.15(2), 285–290 (1988).
  • Dearnaley DP, A’Hern RP, Whittaker S, Bloom HJ. Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962–1987. Int. J. Radiat. Oncol. Biol. Phys.18(4), 773–781 (1990).
  • Huh SJ, Shin KH, Kim IH, Ahn YC, Ha SW, Park CI. Radiotherapy of intracranial germinomas. Radiother. Oncol.38(1), 19–23 (1996).
  • Shirato H, Nishio M, Sawamura Y et al. Analysis of long-term treatment of intracranial germinoma. Int. J. Radiat. Oncol. Biol. Phys.37(3), 511–515 (1997).
  • Sung DI, Harisliadis L, Chang CH. Midline pineal tumors and suprasellar germinomas: highly curable by irradiation. Radiology128(3), 745–751 (1978).
  • Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J. Clin. Oncol.22(4), 706–713 (2004).
  • Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol.5(7), 399–408 (2004).
  • Staudt M, Schropp C, Staudt F et al. MRI assessment of myelination: an age standardization. Pediatr. Radiol.24(2), 122–127 (1994).
  • Silber JH, Radcliffe J, Peckham V et al. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J. Clin. Oncol.10(9), 1390–1396 (1992).
  • Ogawa K, Shikama N, Toita T et al. Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients. Int. J. Radiat. Oncol. Biol. Phys.58(3), 705–713 (2004).
  • Linstadt D, Wara WM, Edwards MS, Hudgins RJ, Sheline GE. Radiotherapy of primary intracranial germinomas: the case against routine craniospinal irradiation. Int. J. Radiat. Oncol. Biol. Phys.15(2), 291–297 (1988).
  • Dattoli MJ, Newall J. Radiation therapy for intracranial germinoma: the case for limited volume treatment. Int. J. Radiat. Oncol. Biol. Phys.19(2), 429–433 (1990).
  • Sugiyama K, Uozumi T, Arita K et al. Clinical evaluation of 33 patients with histologically verified germinoma. Surg. Neurol.42(3), 200–210 (1994).
  • Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK. Radiation therapy for primary intracranial germ-cell tumors. Int. J. Radiat. Oncol. Biol. Phys.32(4), 943–949 (1995).
  • Haas-Kogan DA, Missett BT, Wara WM et al. Radiation therapy for intracranial germ cell tumors. Int. J. Radiat. Oncol. Biol. Phys.56(2), 511–518 (2003).
  • Rogers SJ, Mosleh-Shirazi MA, Saran FH. Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol.6(7), 509–519 (2005).
  • Kawabata Y, Takahashi JA, Arakawa Y, Shirahata M, Hashimoto N. Long term outcomes in patients with intracranial germinomas: a single institution experience of irradiation with or without chemotherapy. J. Neurooncol. DOI: 10.1007/s11060–008–9542–4 (2008) (Epub ahead of print).
  • Allen JC, Kim JH, Packer RJ. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J. Neurosurg.67(1), 65–70 (1987).
  • Nguyen QN, Chang EL, Allen PK et al. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer107(9), 2228–2236 (2006).
  • Lafay-Cousin L, Millar BA, Mabbott D et al. Limited-field radiation for bifocal germinoma. Int. J. Radiat. Oncol. Biol. Phys.65(2), 486–492 (2006).
  • Timmerman RD, Patel D, Boaz JC, Goldman J, Jakacki RI. Patterns of failure after induction chemotherapy followed by consolidative radiation therapy for children with central nervous system germinoma. Med. Pediatr. Oncol.41(6), 564–566 (2003).
  • Aoyama H, Shirato H, Ikeda J, Fujieda K, Miyasaka K, Sawamura Y. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J. Clin. Oncol.20(3), 857–865 (2002).
  • Douglas JG, Rockhill JK, Olson JM, Ellenbogen RG, Geyer JR. Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas. J. Pediatr. Hematol. Oncol.28(1), 36–39 (2006).
  • Silvani A, Eoli M, Salmaggi A et al. Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study. J. Neurooncol.71(3), 271–276 (2005).
  • Buckner JC, Peethambaram PP, Smithson WA et al. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors. J. Clin. Oncol.17(3), 933–940 (1999).
  • Bouffet E, Baranzelli MC, Patte C et al. Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience. Societe Francaise d’Oncologie Pediatrique. Br. J. Cancer79(7–8), 1199–1204 (1999).
  • Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children’s Oncology Group. Pediatr. Blood Cancer48(3), 285–291 (2007).
  • Kellie SJ, Boyce H, Dunkel IJ et al. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatr. Blood Cancer43(2), 126–133 (2004).
  • Balmaceda C, Heller G, Rosenblum M et al. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J. Clin. Oncol.14(11), 2908–2915 (1996).
  • Sands SA, Kellie SJ, Davidow AL et al. Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study. Neuro-oncology3(3), 174–183 (2001).
  • Sutton LN, Radcliffe J, Goldwein JW et al. Quality of life of adult survivors of germinomas treated with craniospinal irradiation. Neurosurgery45(6), 1292–1297 (1999).
  • Merchant TE, Sherwood SH, Mulhern RK et al. CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int. J. Radiat. Oncol. Biol. Phys.46(5), 1171–1176 (2000).
  • Osuka S, Tsuboi K, Takano S et al. Long-term outcome of patients with intracranial germinoma. J. Neurooncol.83(1), 71–79 (2007).
  • Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for pediatric tumors. Cancer97(10), 2588–2596 (2003).
  • Mertens AC, Yasui Y, Neglia JP et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J. Clin. Oncol.19(13), 3163–3172 (2001).
  • Swerdlow AJ, Douglas AJ, Vaughan Hudson G, Vaughan Hudson B, MacLennan KA. Risk of second primary cancer after Hodgkin’s disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin’s disease, and splenectomy. Br. J. Cancer68(5), 1006–1011 (1993).
  • Henry-Amar M. Second cancer after the treatment for Hodgkin’s disease: a report from the International Database on Hodgkin’s Disease. Ann. Oncol.3(Suppl. 4), 117–128 (1992).
  • Shin KH, Kim IH, Choe G. Impacts of elevated level of hCG in serum on clinical course and radiotherapy results in the histology-confirmed intracranial germinomas. Acta Oncol.40(1), 98–101 (2001).
  • Brada M, Rajan B. Spinal seeding in cranial germinoma. Br. J. Cancer61(2), 339–340 (1990).
  • Takeshima H, Kaji M, Uchida H, Hirano H, Kuratsu J. Expression and distribution of c-kit receptor and its ligand in human CNS germ cell tumors: a useful histological marker for the diagnosis of germinoma. Brain Tumor Pathol.21(1), 13–16 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.